alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
**Exhibit 32**

 

CERTIFICATIONPURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002(SUBSECTIONS (a) AND (b) OF SECTION 1350, CHAPTER 63 OFTITLE 18, UNITED STATES CODE)

 

Pursuantto Section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and(b) of section 1350, chapter 63 of Title 18, United States Code), theundersigned officers of Cantel Medical Corp. (the “Company”), do hereby certifywith respect to the Annual Report of the Company on Form 10-K for the yearended July 31, 2010 as filed with the Securities and ExchangeCommission  (the “Form 10-K”) that,to the best of their knowledge:

 

1.    The Form 10-K fullycomplies with the requirements of Section 13(a) or 15(d) of theSecurities Exchange Act of 1934; and

 

2.    The information contained inthe Form 10-K fairly presents, in all material respects, the financialcondition and results of operations of the Company.

 

Date:  October 14, 2010

 

 
|   | /s/  Andrew A. Krakauer                       |
|--------|-----------------------------------------------|
|   | Andrew  A. Krakauer                           |
|   | President  and Chief Executive Officer        |
|   | (Principal  Executive Officer)                |
|   |                                          |
|   | /s/  Craig A. Sheldon                         |
|   | Craig  A. Sheldon                             |
|   | Senior  Vice President, Chief Financial       |
|   | Officer  and Treasurer                        |
|   | (Principal  Financial and Accounting Officer) |

 

----
[Federal Register Volume 88, Number 239 (Thursday, December 14, 2023)]
[Notices]
[Page 86623]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-27483]


-----------------------------------------------------------------------

DEPARTMENT OF COMMERCE

Foreign-Trade Zones Board

[S-233-2023]


Foreign-Trade Zone 24; Application for Subzone; GMA Accessories 
DBA Capelli New York; Pittston, Pennsylvania

    An application has been submitted to the Foreign-Trade Zones (FTZ) 
Board by the Eastern Distribution Center, Inc., grantee of FTZ 24, 
requesting subzone status for the facility of GMA Accessories DBA 
Capelli New York (Capelli), located in Pittston, Pennsylvania. The 
application was submitted pursuant to the provisions of the Foreign-
Trade Zones Act, as amended (19 U.S.C. 81a-81u), and the regulations of 
the FTZ Board (15 CFR part 400). It was formally docketed on December 
8, 2023.
    The proposed subzone (28.08 acres) is located at 901 Sathers Drive, 
Pittston, Pennsylvania. No authorization for production activity has 
been requested at this time. The proposed subzone would be subject to 
the existing activation limit of FTZ 24.
    In accordance with the FTZ Board's regulations, Juanita Chen of the 
FTZ Staff is designated examiner to review the application and make 
recommendations to the Executive Secretary.
    Public comment is invited from interested parties. Submissions 
shall be addressed to the FTZ Board's Executive Secretary and sent to: 
<a href="/cdn-cgi/l/email-protection#ddbba9a79da9afbcb9b8f3bab2ab"><span class="__cf_email__" data-cfemail="2543515f6551574441400b424a53">[email protected]</span></a>. The closing period for their receipt is January 23, 
2024. Rebuttal comments in response to material submitted during the 
foregoing period may be submitted during the subsequent 15-day period 
to February 7, 2024.
    A copy of the application will be available for public inspection 
in the ``Online FTZ Information Section'' section of the FTZ Board's 
website, which is accessible via www.trade.gov/ftz.
    For further information, contact Juanita Chen at 
<a href="/cdn-cgi/l/email-protection#b9d3ccd8d7d0cdd897dad1dcd7f9cdcbd8dddc97ded6cf"><span class="__cf_email__" data-cfemail="95ffe0f4fbfce1f4bbf6fdf0fbd5e1e7f4f1f0bbf2fae3">[email protected]</span></a>.

    Dated: December 11, 2023.
Elizabeth Whiteman,
Executive Secretary.
[FR Doc. 2023-27483 Filed 12-13-23; 8:45 am]
BILLING CODE 3510-DS-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
**Exhibit 32**

 

**CERTIFICATIONS OF CEO AND CFOPURSUANT TO**

**18 U.S.C. SECTION 1350,**

**AS ADOPTED PURSUANT TO**

**SECTION 906 OF THESARBANES-OXLEY ACT OF 2002**

 

In connection with the Quarterly Report on Form 10-Q ofDendrite International, Inc. (the “Company”) for the quarterly period ended March 31,2005 as filed with the Securities and Exchange Commission on the date hereof(the “Report”), John E. Bailye, as Chief Executive Officer of the Company, andKathleen E. Donovan, as Chief Financial Officer, each hereby certifies,pursuant to 18 U.S.C. Section 1350, as adopted pursuant toSection 906 of the Sarbanes-Oxley Act of 2002, that, to the best of his orher knowledge:

 

(1) The Report fully complies with the requirements ofsection 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(2) The information contained in the Report fairlypresents, in all material respects, the financial condition and results ofoperations of the Company.

 

 
| /s/ John E. Bailye       |                                               |
|--------------------------|----------------------------------------------------|
| Name:                    | John E. Bailye                                     |
| Title:                   | Chairman of the Board and  Chief Executive Officer |
| Date:                    | May 10, 2005                                  |
|                     |                                               |
|                     |                                               |
| /s/  Kathleen E. Donovan |                                               |
| Name:                    | Kathleen E. Donovan                                |
| Title:                   | Senior Vice President and  Chief Financial Officer |
| Date:                    | May 10, 2005                                  |
|                          |                                                    |  |

 

----
# C_2022389EN.01002401.xml

| 10.10.2022 | EN | Official Journal of the European Union | C 389/24 |
| --- | --- | --- | --- |

10.10.2022

EN

Official Journal of the European Union

C 389/24

---

Order of the General Court of 25 August 2022 — Silgan Closures and Silgan Holdings v Commission

(Case T-415/18) (1)

(2022/C 389/27)

Language of the case: German

The President of the Ninth Chamber has ordered that the case be removed from the register.

---

(1)  OJ C 294, 20.8.2018.

---
1... See Tex. R. App. P. 47.4.

2... See Tex. Code Crim. Proc. Ann. art. 62.102 (Vernon 2006).

COURT OF APPEALS

SECOND DISTRICT OF TEXAS

FORT WORTH

NO. 2-08-075-CR

DERYL DANIELLE WARE APPELLANT

V.

THE STATE OF TEXAS STATE

------------

FROM THE 396TH DISTRICT COURT OF TARRANT COUNTY

------------

MEMORANDUM OPINION1

------------

Appellant Deryl Danielle Ware appeals his conviction for failure to register

as a sex offender.2 We affirm. 

Appellant’s court-appointed appellate counsel has filed a motion to

withdraw as counsel and a brief in support of that motion. In the brief, counsel
3... 386 U.S. 738, 87 S. Ct. 1396 (1967).

4... See Stafford v. State, 813 S.W.2d 503, 511 (Tex. Crim. App. 1991);

Mays v. State, 904 S.W.2d 920, 922–23 (Tex. App.—Fort Worth 1995, no

pet.).

5... See Penson v. Ohio, 488 U.S. 75, 82–83, 109 S. Ct. 346, 351

(1988).

6... See Bledsoe v. State, 178 S.W.3d 824, 827–28 (Tex. Crim. App.

2005); Meza v. State, 206 S.W.3d 684, 685 n.6 (Tex. Crim. App. 2006).

2

avers that, in his professional opinion, this appeal is frivolous. Counsel’s brief

and motion meet the requirements of Anders v. California3 by presenting a

professional evaluation of the record demonstrating why there are no arguable

grounds for relief. We gave appellant the opportunity to file a pro se brief, and

he has filed one. In addition, the State has filed a letter brief.

Once an appellant’s court-appointed attorney files a motion to withdraw

on the ground that the appeal is frivolous and fulfills the requirements of

Anders, this court is obligated to undertake an independent examination of the

record.4 Only then may we grant counsel’s motion to withdraw.

5

We have carefully reviewed the record, counsel’s brief, appellant’s pro se

brief and supplement, and the State’s brief. We agree with counsel that this

appeal is wholly frivolous and without merit; we find nothing in the record that

might arguably support the appeal.6 Accordingly, we grant counsel’s motion

to withdraw and affirm the trial court’s judgment. 
3

PER CURIAM

PANEL: CAYCE, C.J.; LIVINGSTON and MCCOY, JJ.

DO NOT PUBLISH

Tex. R. App. P. 47.2(b)

DELIVERED: October 9, 2008
[Federal Register Volume 88, Number 239 (Thursday, December 14, 2023)]
[Notices]
[Page 86663]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-27422]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of General Medical Sciences; Notice of Closed 
Meeting

    Pursuant to section 1009 of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of General Medical 
Sciences Special Emphasis Panel; NIGMS Review of Applications for 
Innovative Programs to Enhance Research Training (IPERT) (R25), 
MOSAIC (UE5), and Conference (R13) Applications.
    Date: March 6-7, 2024.
    Time: 10:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, National Institute of 
General Medical Sciences, Natcher Building, 45 Center Drive, 
Bethesda, Maryland 20892 (Virtual Meeting).
    Contact Person: Latarsha J. Carithers, Ph.D., Scientific Review 
Officer, Office of Scientific Review, National Institute of General 
Medical Sciences, National Institutes of Health, 45 Center Drive, 
Room 3AN12C, Bethesda, Maryland 20892, 301-594-4859, 
<a href="/cdn-cgi/l/email-protection#bfd3decbdecdccd7de91dcdecdd6cbd7dacdccffd1d6d791d8d0c9"><span class="__cf_email__" data-cfemail="c0aca1b4a1b2b3a8a1eea3a1b2a9b4a8a5b2b380aea9a8eea7afb6">[email protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program No. 93.859, 
Biomedical Research and Research Training, National Institutes of 
Health, HHS)

    Dated: December 8, 2023.
Miguelina Perez,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2023-27422 Filed 12-13-23; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
#### Mundell v. State

16552

4/26/95

Affirmed
#### State v. Owens.

27714

08/10/2007

Granted

113 Hawai'i 472, 155 P.3d 655
Exhibit 32.02




CERTIFICATION OF CHIEF FINANCIAL OFFICER REQUIRED BY
RULE 13a-14(b) or RULE 15d-14(b) AND SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002, 18 U.S.C. SECTION 1350




In connection with the Annual Report of Williams Controls,
Inc (the Company) on Form 10-K for the period ended September 30, 2005 as filed with the Securities and Exchange Commission on the date
hereof (the Report), I, Dennis E. Bunday, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. ss. 1350, as adopted
pursuant to ss. 906 of the Sarbanes-Oxley Act of 2002, that:


|(1) |  | The Report fully complies with the requirements of section 13(a)
or 15(d) of the Securities Exchange Act of 1934; and
|--- |  | ---------------------------------------------------------------------------------------------------------------------

|(2) |  | The information contained in the Report fairly presents, in all
material respects, the financial condition and result of operations of the Company.
|--- |  | ---------------------------------------------------------------------------------------------------------------------------------------------------



/s/ DENNIS E. BUNDAY Dennis E. Bunday Chief Financial Officer Williams Controls, Inc December 7,
2005


---
#### State v. Ortiz

20498

1/26/98

Vacated and Remanded
# C_2019305EN.01005301.xml

| 9.9.2019 | EN | Official Journal of the European Union | C 305/53 |
| --- | --- | --- | --- |

9.9.2019

EN

Official Journal of the European Union

C 305/53

---

Judgment of the General Court of 12 July 2019 — mobile.de v EUIPO — Droujestvo S Ogranichena Otgovornost ‘Rezon’ (mobile.ro)

(Case T-412/18) (1)

(EU trade mark - Invalidity proceedings - EU figurative mark mobile.ro - Earlier national figurative mark mobile - Genuine use of the earlier mark - Article 18 of Regulation (EU) 2017/1001 - Relative ground for refusal - Likelihood of confusion - Article 8(1)(b) of Regulation 2017/1001)

(2019/C 305/63)

Language of the case: English

Parties

Applicant: mobile.de GmbH (Dreilinden, Germany) (represented by: T. Lührig, lawyer)

Defendant: European Union Intellectual Property Office (represented by: J. Crespo Carrillo and H. O’Neill, acting as Agents)

Other party to the proceedings before the Board of Appeal of EUIPO, intervener before the General Court: Droujestvo S Ogranichena Otgovornost ‘Rezon’ (Sofia, Bulgaria) (represented by: M. Yordanova-Harizanova and V. Grigorova, lawyers)

Re:

Action brought against the decision of the First Board of Appeal of EUIPO of 29 March 2018 (Case R 111/2015-1), relating to invalidity proceedings between Droujestvo S Ogranichena Otgovornost ‘Rezon’ and mobile.de.

Operative part of the judgment

The Court:

| 1. | Dismisses the action; |
| --- | --- |

1.

Dismisses the action;

| 2. | Orders mobile.de GmbH to bear its own costs and to pay those incurred by the European Union Intellectual Property Office (EUIPO) and by Droujestvo S Ogranichena Otgovornost ‘Rezon’. |
| --- | --- |

2.

Orders mobile.de GmbH to bear its own costs and to pay those incurred by the European Union Intellectual Property Office (EUIPO) and by Droujestvo S Ogranichena Otgovornost ‘Rezon’.

---

(1)  OJ C 294, 20.8.2018.

---
If this opinion indicates that it is “FOR PUBLICATION,” it is subject to 

revision until final publication in the Michigan Appeals Reports.

-1-

S T A T E O F M I C H I G A N

C O U R T O F A P P E A L S

PEOPLE OF THE STATE OF MICHIGAN,

Plaintiff-Appellee,

UNPUBLISHED

November 19, 2020

v No. 349105

Wayne Circuit Court

DWIGHT ANDREW JONES, LC No. 18-002173-01-FC

Defendant-Appellant.

Before: GLEICHER, P.J., and K. F. KELLY and SHAPIRO, JJ.

K. F. KELLY, J. (concurring and dissenting). 

I join in the majority opinion in all respects except sentencing. Rather, I would conclude 

that the trial court did not abuse its discretion by imposing consecutive sentences. 

As the majority observes, a trial court’s decision whether to impose a discretionary 

consecutive sentence is reviewed for an abuse of discretion. People v Norfleet, 317 Mich App 

649, 654; 897 NW2d 195 (2016). Although concurrent sentencing is the norm, a consecutive 

sentence may be imposed only if specifically authorized by statute, People v Ryan, 295 Mich App 

388, 401; 819 NW2d 55 (2012), and consecutive sentencing applicable to this case is set forth in

MCL 750.520b(3). The purpose of consecutive-sentencing statutes is to deter individuals from 

committing multiple crimes by removing the security of concurrent sentences, and the Legislature 

intended real and substantial consequences by authorizing the imposition of lengthy prison terms. 

Ryan, 295 Mich App at 408. 

In this case, the trial court justified its imposition of consecutive sentences by commenting 

on the egregious nature of defendant’s conduct, which involved multiple acts of sexual penetration 

committed against defendant’s own five-year-old daughter, the court’s opinion that defendant was 

a sexual predator, and the absurdity of defendant’s defense that he simply awoke to find his 

daughter’s mouth on his penis. Indeed, the record indicates that defendant removed his child from 

her siblings and committed multiple acts of penetration, including vaginal penetration that caused 

her to bleed. Further, defendant merely asserted that he was asleep naked and awoke to find the 

victim touching his penis and part of his penis was in her mouth. Defendant opined that the victim 

was not being “all the way truthful.” Under the circumstances, the trial court adequately articulated 
-2-

its reasons for ordering defendant’s sentences to be served consecutively, and I cannot conclude 

that the sentences imposed were outside the range of reasonable and principled outcomes. 

I would affirm defendant’s convictions and sentences. 

/s/ Kirsten Frank Kelly
## F IRST 

## D ISTRICT 

## C OURT OF 

## A PPEAL 

## S TATE OF 

## F LORIDA

_____________________________
No. 1D 19

- 976

_____________________________
E LIJAH M OORE , J R

. , Appellant,

v.

S TATE O F F LORIDA , Appellee.

_____________________________

On appeal from the Circuit Court for Taylor County

. Gregory S. Parker , Judge

. September 18, 2019

P ER C URIAM

.
A FFIRMED

.
L EWIS , O STERHAUS , and K ELSEY , JJ., concur

.

_____________________________ Not final until disposition of any timely and authorized motion under Fla. R. App. P. 9.330 or 9.331

.

_____________________________2 Elijah Moore, Jr., pro se
, Appellant.

Ashley Moody, Attorney General, and Quentin Humphrey, Assistant Attorney General, Tallahassee
, for Appellee.
<TABLE> <S> <C>

<ARTICLE> 5
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          OCT-31-1999
<PERIOD-END>                               JAN-31-1999
<CASH>                                           18826
<SECURITIES>                                         0
<RECEIVABLES>                                        0
<ALLOWANCES>                                         0
<INVENTORY>                                     358291
<CURRENT-ASSETS>                                     0
<PP&E>                                            5873
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                                  437544
<CURRENT-LIABILITIES>                                0
<BONDS>                                         149300
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                           112
<OTHER-SE>                                      166122
<TOTAL-LIABILITY-AND-EQUITY>                    437544
<SALES>                                         144433
<TOTAL-REVENUES>                                150719
<CGS>                                           122578
<TOTAL-COSTS>                                   122578
<OTHER-EXPENSES>                                 20478
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                                   7663
<INCOME-TAX>                                      2958
<INCOME-CONTINUING>                               4705
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                      4705
<EPS-PRIMARY>                                      .42
<EPS-DILUTED>                                      .42
        

</TABLE>
**Exhibit 32**

 

**CERTIFICATIONS OF CEO AND CFOPURSUANT TO**

**18 U.S.C. SECTION 1350,**

**AS ADOPTED PURSUANT TO**

**SECTION 906 OF THESARBANES-OXLEY ACT OF 2002**

 

In connection with the Quarterly Report on Form 10-Q ofDendrite International, Inc. (the “Company”) for the quarterly period endedSeptember 30, 2004 as filed with the Securities and Exchange Commission onthe date hereof (the “Report”), John E. Bailye, as Chief Executive Officer ofthe Company, and Kathleen E. Donovan, as Chief Financial Officer, each hereby certifies,pursuant to 18 U.S.C. Section 1350, as adopted pursuant toSection 906 of the Sarbanes-Oxley Act of 2002, that, to the best of his orher knowledge:

 

(1) The Report fully complies with the requirements ofsection 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(2) The information contained in the Report fairlypresents, in all material respects, the financial condition and results ofoperations of the Company.

 

 
| /s/ John E. Bailye       |                                               |
|--------------------------|----------------------------------------------------|
| Name:                    | John E. Bailye                                     |
| Title:                   | Chairman of the Board and  Chief Executive Officer |
| Date:                    | November 8, 2004                                   |
|                     |                                               |
|                     |                                               |
| /s/  Kathleen E. Donovan |                                               |
| Name:                    | Kathleen E. Donovan                                |
| Title:                   | Senior Vice President and  Chief Financial Officer |
| Date:                    | November 8, 2004                                   |
|                          |                                                    |  |

 

----
22705

#### State v. Kapika

Remanded